Northern Trust’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-919,895
| Closed | -$17.9M | – | 4380 |
|
|
2018
Q1 | $17.9M | Sell |
919,895
-5,291
| -0.6% | -$104K | ﹤0.01% | 1769 |
|
|
2017
Q4 | $15.4M | Sell |
925,186
-13,009
| -1% | -$238K | ﹤0.01% | 1910 |
|
|
2017
Q3 | $19M | Sell |
938,195
-5,509
| -0.6% | -$105K | 0.01% | 1742 |
|
|
2017
Q2 | $15.2M | Buy |
943,704
+7,913
| +0.8% | +$117K | ﹤0.01% | 1890 |
|
|
2017
Q1 | $11.8M | Sell |
935,791
-55,201
| -6% | -$667K | ﹤0.01% | 2006 |
|
|
2016
Q4 | $13.1M | Sell |
990,992
-27,619
| -3% | -$472K | ﹤0.01% | 1910 |
|
|
2016
Q3 | $24.1M | Sell |
1,018,611
-2,327
| -0.2% | -$62.5K | 0.01% | 1439 |
|
|
2016
Q2 | $29.4M | Buy |
1,020,938
+29,243
| +3% | +$953K | 0.01% | 1200 |
|
|
2016
Q1 | $32M | Buy |
991,695
+17,254
| +2% | +$607K | 0.01% | 1113 |
|
|
2015
Q4 | $41.7M | Buy |
974,441
+20,092
| +2% | +$803K | 0.01% | 933 |
|
|
2015
Q3 | $33.6M | Buy |
954,349
+4,656
| +0.5% | +$210K | 0.01% | 1072 |
|
|
2015
Q2 | $43.6M | Sell |
949,693
-39,930
| -4% | -$1.9M | 0.01% | 960 |
|
|
2015
Q1 | $46.4M | Buy |
989,623
+22,160
| +2% | +$882K | 0.01% | 923 |
|
|
2014
Q4 | $30.6M | Sell |
967,463
-24,009
| -2% | -$703K | 0.01% | 1194 |
|
|
2014
Q3 | $23.5M | Buy |
991,472
+25,454
| +3% | +$652K | 0.01% | 1372 |
|
|
2014
Q2 | $29M | Sell |
966,018
-123,025
| -11% | -$3.32M | 0.01% | 1218 |
|
|
2014
Q1 | $28.8M | Buy |
1,089,043
+632
| +0.1% | +$15.8K | 0.01% | 1260 |
|
|
2013
Q4 | $27.4M | Buy |
1,088,411
+12,580
| +1% | +$281K | 0.01% | 1259 |
|
|
2013
Q3 | $22M | Buy |
1,075,831
+18,422
| +2% | +$380K | 0.01% | 1386 |
|
|
2013
Q2 | $21.1M | Buy |
+1,057,409
| New | +$18.8M | 0.01% | 1333 |
|
Northern Trust's IPXL Position: Q2 2018 in Review
Northern Trust sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 919,895 shares — an estimated $17.9M sold.
Northern Trust first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $46.4M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Northern Trust reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Northern Trust sold 919,895 Impax Laboratories, Inc. shares in Q2 2018, an estimated $17.9M.
- Northern Trust first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Northern Trust's Impax Laboratories, Inc. position peaked at $46.4M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Northern Trust's 13F filing for Q2 2018, filed 14 Aug 2018.